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ractional  ﬂow  reserve  for  guidance  in  intervention  of  multiple  sequential  lesionsFractional ﬂow reserve (FFR) is a well-established index for
etermining the signiﬁcance of stenosis, and provides useful infor-
ation in decision-making for the indication of revascularization.
FR-guided percutaneous coronary intervention (PCI) has been
ecently upgraded to an IA classiﬁcation for multivessel disease
n the Guidelines on Coronary Revascularization of the European
ociety of Cardiology [1].  FFR can be useful not only for the indica-
ion of intervention but also for decision-making at the end of PCI
rocedures, especially in diffuse and multiple lesions. In this issue
f the Journal of Cardiology Cases, Kurisu et al. [2] report a case in
hich FFR was applied to the PCI procedure in multiple sequen-
ial stenoses, and transient stenosis by myocardial bridging was
ssessed; these two points are discussed here.
The concept of FFR was ﬁrst introduced by Pijls as an index for
he functional signiﬁcance of coronary artery stenosis [3].  FFR is
eﬁned as the ratio of maximum blood ﬂow in a stenotic artery
elative to maximum blood ﬂow if that same artery were to be nor-
al. In other words, FFR represents the degree by which maximum
lood ﬂow is limited in the presence of a stenosis. For example,
f FFR is 0.75, it means that maximum blood ﬂow reaches only
5% of its normal value. FFR can be calculated as the ratio of distal
ressure over aortic pressure obtained during maximum hyper-
mia. FFR indicates the signiﬁcance of the lesion in every vessel
4,5], during the entire PCI procedure [6].  In patients with mul-
ivessel disease, FFR allows us to grade the functional severity of
he patient and to predict the outcome after PCI. The use of FFR
as aided decision-making, achieving a favorable revascularization
utcome [7–9].
In the coronary blood stream from aorta to coronary vein, FFR
eﬂects the total amount of resistance to coronary blood ﬂow. Thus,
hen several stenoses are present in the same artery, distal coro-
ary ﬂow is regulated by the sum of the resistance in each stenosis.
n the case of diffuse-long stenosis, distal coronary ﬂow is regu-
ated by the sum of the resistance in the entire length of the vessel.
or clinical practice, a pull-back recording of coronary pressure at
aximum hyperemia provides important information. Pull-back
ecording reveals the most critical stenosis in the artery; however,
emodynamic severity of the individual stenosis is always under-
stimated. The existence of multiple stenoses can cause a decrease
n blood ﬂow at each stenosis, and then the pressure gradient at
ach stenosis can be lower than that at the stenosis if it were a sin-
le lesion in a vessel. The severity of the individual stenosis could
heoretically be predicted by calculation from coronary pressure
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ttp://dx.doi.org/10.1016/j.jccase.2012.09.004and coronary wedge pressure [10,11]. The equation for determin-
ing the FFR of individual stenosis in multiple sequential stenoses is
as follows:
FFR(A)pred =
Pd − (Pm/Pa)Pw
Pa − Pm + Pd − Pw
FFR(B)pred = 1 −
(Pa − Pw)(Pm − Pd)
Pa(Pm − Pw)
Pa, Pm, Pd, and Pw indicate mean hyperemic aortic pressure, mean
hyperemic coronary pressure between both lesions, mean hyper-
emic distal coronary pressure distal to the most distal lesion,
and coronary wedge pressure, respectively. The proximal lesion is
called stenosis A, the distal stenosis is B, and the FFR associated with
each lesion is indicated by FFR(A) and FFR(B), respectively. FFRpred
indicates the value of FFR predicted from the pressure measure-
ments before PCI.
In this equation, measurement of Pw is mandatory, which
means that balloon dilatation of at least one lesion should be
performed. Thus, FFRpred cannot be evaluated before PCI. In daily
clinical practice, we  have to decide the PCI strategy based on func-
tional information by pull-back recording of coronary pressure and
anatomical information such as lesion length and the status of
the branches. To understand the true hemodynamic signiﬁcance
of residual stenosis, we should re-evaluate the FFR after stenting
for one lesion. We  should be aware that the true severity of the
second stenosis will be unmasked by the increased maximum ﬂow
after the elimination of the ﬁrst stenosis.
Notably, this strategy and equation assume that all stenoses
are ﬁxed, although it is not uncommon for transient stenosis by
myocardial bridging to be concomitant with ﬁxed stenosis. In the
case reported by Kurisu et al., FFR of the left anterior descending
artery (LAD) with both ﬁxed stenosis and myocardial bridging was
0.71, indicating that the myocardial ischemia was positive in the
LAD territory. Even if there were several stenoses in one vessel,
the decrease in FFR suggests reversible ischemia at least distally to
the measured vessel territory. This ﬁnding supports the indication
of PCI. However, it is unclear whether sufﬁcient improvement in
FFR can be gained by stenting alone for the most severe lesion.
They implanted one stent for ﬁxed stenosis, and then FFR was
re-evaluated. FFR improved to 0.82 after stenting, and pull-back
recording showed a small pressure gradient remaining at the site
of myocardial bridging.
Myocardial bridging is commonly found in routine angiogra-
phy and is accepted as a harmless variant; however, it has been
associated with myocardial ischemia, infarction, and sudden death
vier Ltd. All rights reserved.
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12,13].  Although surgical treatment and coronary stenting were
erformed for myocardial bridging, the long-term results remain
nclear. Thus, we should avoid unnecessary interventions, and
ather assess the physiological signiﬁcance of myocardial bridging.
he mechanisms of ischemia in myocardial bridging include sys-
olic compression and failure of diastolic vascular relaxation, and
t is difﬁcult to determine the signiﬁcance by coronary angiogra-
hy alone. FFR is widely used for determining the physiological
igniﬁcance of myocardial bridging as in ﬁxed stenosis. Moreover,
iastolic FFR has a higher sensitivity compared to conventional FFR
or detection of ischemia in patients with myocardial bridging [14].
obutamine infusion leads to a diastolic pressure gradient owing to
ncreased contractility of muscle ﬁbers overlying the arterial seg-
ent. Consequently, diastolic FFR after dobutamine infusion can
etter identify its signiﬁcance compared to conventional FFR [15].
In the case reported by Kurisu et al., the pressure gradient
emained at the site of myocardial bridging even after stenting for
xed stenosis. As the FFR value was >0.80, they decided to defer
he additional stent implantation. However, if they used inotropic
timulation by dobutamine infusion during FFR measurements,
he pressure gradient could have been greater. FFR after dobut-
mine infusion for the assessment of physiological signiﬁcance of
yocardial bridging may  have different clinical signiﬁcance than
onventional FFR, although we do not know yet which would
e more predictable of prognosis. The signiﬁcance of myocardial
ridging and the risk of the patient should be investigated.
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